Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Tau Protein Interaction Partners and Their Roles in Alzheimer's Disease and Other Tauopathies

Sinsky J, Pichlerova K, Hanes J.

Int J Mol Sci. 2021 Aug 26;22(17):9207. doi: 10.3390/ijms22179207.

Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances

Chong JR, Ashton NJ, Karikari TK, Tanaka T, Schöll M, Zetterberg H, Blennow K, Chen CP, Lai MKP.

J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1231-1241. doi: 10.1136/jnnp-2021-327370. Epub 2021 Sep 11.

Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies

Sriwichaiin S, Chattipakorn N, Chattipakorn SC.

J Alzheimers Dis. 2021;84(1):23-50. doi: 10.3233/JAD-210737.

Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis

Salminen A, Kaarniranta K, Kauppinen A.

Neurochem Int. 2021 Nov;150:105186. doi: 10.1016/j.neuint.2021.105186. Epub 2021 Sep 13.

Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach

Sharma S, Behl T, Kumar A, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S.

Biomed Res Int. 2021 Sep 6;2021:7396580. doi: 10.1155/2021/7396580. eCollection 2021.

Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-β Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review

Cianflone A, Coppola L, Mirabelli P, Salvatore M.

J Alzheimers Dis. 2021;84(1):393-407. doi: 10.3233/JAD-210496.

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Janelidze S, Teunissen CE, Zetterberg H, Allué JA, Sarasa L, Eichenlaub U, Bittner T, Ovod V, Verberk IMW, Toba K, Nakamura A, Bateman RJ, Blennow K, Hansson O.

JAMA Neurol. 2021 Nov 1;78(11):1375-1382. doi: 10.1001/jamaneurol.2021.3180.

A(2A) Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease

Gessi S, Poloni TE, Negro G, Varani K, Pasquini S, Vincenzi F, Borea PA, Merighi S.

Cells. 2021 Sep 7;10(9):2344. doi: 10.3390/cells10092344.

On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer's Disease

Kriska J, Hermanova Z, Knotek T, Tureckova J, Anderova M.

Int J Mol Sci. 2021 Sep 7;22(18):9689. doi: 10.3390/ijms22189689.

Should We Open Fire on Microglia? Depletion Models as Tools to Elucidate Microglial Role in Health and Alzheimer's Disease

Romero-Molina C, Navarro V, Jimenez S, Muñoz-Castro C, Sanchez-Mico MV, Gutierrez A, Vitorica J, Vizuete M.

Int J Mol Sci. 2021 Sep 8;22(18):9734. doi: 10.3390/ijms22189734.

A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease

Senda M, Ishii K, Ito K, Ikeuchi T, Matsuda H, Iwatsubo T, Iwata A, Ihara R, Suzuki K, Kasuga K, Ikari Y, Niimi Y, Arai H, Tamaoka A, Arahata Y, Itoh Y, Tachibana H, Ichimiya Y, Washizuka S, Odawara T, Ishii K, Ono K, Yokota T, Nakanishi A, Matsubara E, Mori H, Shimada H.

J Prev Alzheimers Dis. 2021;8(4):495-502. doi: 10.14283/jpad.2021.37.

The Impact of Ageing on the CNS Immune Response in Alzheimer's Disease

Chee SEJ, Solito E.

Front Immunol. 2021 Sep 17;12:738511. doi: 10.3389/fimmu.2021.738511. eCollection 2021.

PET Imaging of Neuroinflammation in Alzheimer's Disease

Zhou R, Ji B, Kong Y, Qin L, Ren W, Guan Y, Ni R.

Front Immunol. 2021 Sep 16;12:739130. doi: 10.3389/fimmu.2021.739130. eCollection 2021.

Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services-part 2 of 6

Ranson JM, Rittman T, Hayat S, Brayne C, Jessen F, Blennow K, van Duijn C, Barkhof F, Tang E, Mummery CJ, Stephan BCM, Altomare D, Frisoni GB, Ribaldi F, Molinuevo JL, Scheltens P, Llewellyn DJ; European Task Force for Brain Health Services.

Alzheimers Res Ther. 2021 Oct 11;13(1):169. doi: 10.1186/s13195-021-00895-4.

Electroencephalography as a Non-Invasive Biomarker of Alzheimer's Disease: A Forgotten Candidate to Substitute CSF Molecules?

Monllor P, Cervera-Ferri A, Lloret MA, Esteve D, Lopez B, Leon JL, Lloret A.

Int J Mol Sci. 2021 Oct 8;22(19):10889. doi: 10.3390/ijms221910889.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias